Jeffrey R. Burton

Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years

Gerald M. FitzGibbon, Henryk Kafka, Alan J. Leach et al. · Journal of the American College of Cardiology · 1996 · 1.4K citations

Medicine, Cardiology, Surgery +9

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

A. Michael Lincoff, Robert M. Califf, David J. Moliterno et al. · New England Journal of Medicine · 1999 · 379 citations

Medicine, Cardiology, Pharmacotherapy +17

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

Eric J. Topol, Daniel B. Mark, A. Michael Lincoff et al. · The Lancet · 1999 · 329 citations

Medicine, Cardiology, Pharmacoeconomics +16

Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis

Koon Teo, Jeffrey R. Burton, Christopher E. Buller et al. · Circulation · 2000 · 276 citations · Full text

Medicine, Cardiology, Pharmacology +15

VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial

Duncan J. Stewart, Michael J.B. Kutryk, David Fitchett et al. · Molecular Therapy · 2009 · 266 citations · Full text

Medicine, Cardiology, Nuclear Medicine +17